Legal
Terms of use
By using this website you agree to these terms. The content is provided for general information about ImmunoPDT and its clinical-stage programme. It is not medical advice and not an offer of securities. Information may be updated without notice. The gated investor surfaces are access-controlled and provided to approved recipients only.
Clinical-stage statement. Immuno1 is investigational. ImmunoPDT is a clinical-stage company. The therapy is not approved for marketing in any jurisdiction.
Forward-looking statement. This material contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties. Past clinical results are not a guarantee of future outcomes.